SGI
Earnings in 1 day · May 7, 2026 · Before open
Signal
Mixed11
Price
1
Move+1.92%Positive session
Volume
1
Volume1.1× avgNormal activity
Technical
1
TrendFull DowntrendBelow 50D & 200D
PRICE
Prev Close
73.10
Open
73.94
Day Range73.31 – 75.37
73.31
75.37
52W Range56.15 – 98.56
56.15
98.56
43% of range
VOLUME & SIZE
Avg Volume
2.7M
Float
210.3M
FUNDAMENTALS
P/E Ratio
40.5x
Premium valuation
EPS (TTM)
$1.84
Div Yield
No dividend
Performance
1D
+1.92%
5D
-1.59%
1M
+0.17%
3M
-21.45%
6M
-6.41%
YTD
-16.55%
1Y
+20.16%
Best: 1Y (+20.16%)Worst: 3M (-21.45%)
Quick Read
Earnings in 2d · May 7
Trend
DOWNTREND
Price below SMA50 & SMA200
Momentum
BULLISH
revenue +52% YoY · 43% gross margin
Valuation
EXPENSIVE
P/E 40x vs ~20x sector
Health
WEAK
CR 0.8 (low) · FCF $3.02/sh
Bearish
Key MetricsTTM
Market Cap$15.67B
Revenue TTM$7.48B
Net Income TTM$384.10M
Free Cash Flow$633.20M
Gross Margin42.8%
Net Margin5.1%
Operating Margin10.2%
Return on Equity13.2%
Return on Assets3.3%
Debt / Equity2.66
Current Ratio0.83
EPS TTM$1.83
Alpha SignalsFull Analysis →
What Moves This Stock

Organic revenue growth rates and market share gains/losses in core categories versus competitors like P&G, Unilever, Colgate-Palmolive

Gross margin trajectory driven by commodity input costs (resins, surfactants, packaging) and pricing realization

Integration progress and synergy capture from recent M&A activity (implied by 51.6% revenue growth)

E-commerce penetration rates and direct-to-consumer channel performance

Macro Sensitivity
Economic Cycle

low-to-moderate - Household and personal care products are consumer staples with relatively inelastic demand during recessions, as consumers continue purchasing cleaning supplies, toiletries, and basic home care items. However, the company faces trading-down risk where consumers shift to private label during economic stress, and discretionary SKUs (premium variants, specialty products) see volume pressure. The 0.83 current ratio suggests tight working capital management that could be stressed in a downturn.

Interest Rates

Rising rates create moderate headwinds through higher financing costs on the elevated 2.66 debt/equity ratio, increasing interest expense and pressuring net margins. The $0.6B free cash flow provides debt service capacity, but refinancing risk exists if rates remain elevated. Higher rates also pressure valuation multiples for defensive stocks as bond yields become more attractive alternatives. Consumer demand is minimally rate-sensitive given staples positioning, though mortgage rate impacts on housing formation affect household product volumes indirectly.

Key Risks

Private label penetration accelerating as retailers invest in store brands with comparable quality at 20-30% lower prices, particularly in commodity categories like cleaning supplies and basic personal care

E-commerce disruption enabling direct-to-consumer brands to bypass traditional retail distribution, reducing shelf space dominance advantages and increasing customer acquisition costs

Sustainability and ingredient transparency demands requiring reformulation investments and potential margin pressure from natural/clean ingredient sourcing

Investor Profile

growth-at-reasonable-price (GARP) - The 51.6% revenue growth attracts growth investors, while 2.6x price/sales and consumer defensive positioning appeal to investors seeking growth with downside protection. The 31.6% one-year return and positive momentum (8.5% 3-month, 13.0% 6-month) attract momentum investors. However, flat net income growth and -15.8% EPS decline create concern for pure growth investors, suggesting the stock appeals to those betting on margin recovery post-integration. The 3.3% FCF yield is modest, limiting appeal to pure value/dividend investors.

Watch on Earnings
Brent crude oil price (BZUSD) as proxy for petrochemical input costs affecting surfactants, polymers, and packaging resinsUS retail sales ex-auto (RSXFS) indicating consumer spending health and category volume trendsConsumer sentiment index (UMCSENT) as leading indicator for trading-up/down behavior and private label riskCore CPI (CPILFESL) measuring pricing environment and ability to pass through cost inflation
Health Radar
2 watch4 concern
22/100
Liquidity
0.83Concern
Leverage
2.66Concern
Coverage
2.8xWatch
ROE
13.2%Watch
ROIC
5.8%Concern
Cash
$135MConcern
ANALYST COVERAGE11 analysts
BUY
+42.3%upside to target
L $90.00
Med $106.00consensus
H $110.00
Strong Buy
19%
Buy
873%
Hold
218%
9 Buy (82%)2 Hold (18%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 7 signals bullish
3/10
Trend
Trend StateDowntrend (below both MAs)
Above SMA 50$78.82 (-5.5%)
Above SMA 200$84.30 (-11.6%)
Technicals
MA AlignmentDeath Cross (50D vs 200D -6.5%)
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 0.83 — liquidity risk
Upcoming Events
EEarnings ReportMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentAug 10, 2026
In 96 days
Technicals
Market Position
Price Levels
52W High
$98.56+32.3%
SMA 200
$84.30+13.2%
SMA 50
$78.82+5.8%
Current
$74.50
52W Low
$56.15-24.6%
52-Week RangeMid-range
$56.1543th %ile$98.56
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 8 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$7.5B
$7.5B$7.6B
$2.70
±1%
High8
FY2026(current)
$7.9B
$7.8B$8.1B
+5.4%$3.24+20.1%
±3%
High8
FY2027
$8.3B
$8.2B$8.4B
+5.0%$4.04+24.7%
±5%
High8
Range confidence:Tight (high)ModerateWide (low)
Earnings HistorySGI
Last 8Q
+0.9%avg beat
Beat 5 of 8 quartersMissed 2 Estimates rising
-12%
Q1'24
-6%
Q2'24
+1%
Q4'24
+5%
Q1'25
+4%
Q2'25
+4%
Q3'25
+11%
Q4'25
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
Neutral — mixed activity
90d10
JefferiesHold → Buy
Mar 26
UPGRADE
Financials
Dividends0.83% yield
+16.6% avg annual growth
Annual Yield0.83%
Semi-Annual Div.$0.1700
Est. Annual / Share$0.34
FrequencySemi-Annual
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
Allspring Global Investments Holdings, LLC
3.0M
2
UBS Group AG
1.5M
3
Bank of New York Mellon Corp
1.4M
4
ENVESTNET ASSET MANAGEMENT INC
522K
5
PRINCIPAL FINANCIAL GROUP INC
512K
6
Nuveen, LLC
501K
7
Artemis Investment Management LLP
379K
8
Retirement Systems of Alabama
314K
News & Activity

SGI News

20 articles · 4h ago

About

No company information available